この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1997/2/251 分で読めます
Prescription Drug Products; Certain Combined Oral Contraceptives for Use as Postcoital Emergency Contraception
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing that the Commissioner of Food and Drugs (the Commissioner) has concluded that certain combined oral contraceptives containing ethinyl estradiol and norgestrel or levonorgestrel are safe and effective for use as postcoital emergency contraception, and requests submission of new drug applications (NDA's) for this use. This notice is intended to encourage manufacturers to make this additional contraceptive option available.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →